New HIV pill trial seeks to control virus in untreated patients

NCT ID NCT07308782

Recruiting now Disease control Sponsor: Henan Genuine Biotech Co., Ltd. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new oral medication called CL-197 for people with HIV who have never taken any HIV drugs before. The main goal is to see how well a single dose lowers the amount of virus in the blood and to check if it is safe. Researchers will also measure how the drug moves through the body in 24 carefully selected participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Youan Hospital, Capital Medical University
RECRUITING

Beijing, China

Conditions

Explore the condition pages connected to this study.

HIV-1-INFECTION